Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

A Relative Strength Rating upgrade for Krystal Biotech shows improving technical performance. Will it continue?

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...

Stock market whiplash is dampening hopes ... s health agencies injected more uncertainty into the industry. And then came tariffs. “Biotech stocks have experienced heightened volatility in ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

The global Humanized Mouse and Rat Model Market, valued at US$255.8 million in 2024, is forecasted to grow at a robust CAGR ...

"Kyle's decades of financial, transactional and operational experience in our industry will make an immediate and positive ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already ... trials but no products on the market to keep them afloat ...